244 related articles for article (PubMed ID: 32833019)
1. Quality Testing of Difficult-to-Make Prescription Pharmaceutical Products Marketed in the US.
Fisher AC; Viehmann A; Ashtiani M; Friedman RL; Buhse L; Kopcha M; Woodcock J
JAMA Netw Open; 2020 Aug; 3(8):e2013920. PubMed ID: 32833019
[TBL] [Abstract][Full Text] [Related]
2. Dosage unit uniformity and dissolution testing of extended-release pharmaceutical products marketed in the U.S.
Leigh Wood E; Tatke A; Viehmann A; Ashtiani M; Friedman RL; Kopcha M; Fisher AC
Int J Pharm; 2022 Sep; 625():122119. PubMed ID: 36029995
[TBL] [Abstract][Full Text] [Related]
3. "Insight" into drug quality: comparison of simvastatin tablets from the US and Canada obtained via the Internet.
Veronin MA; Lee E; Lewis EN
Ann Pharmacother; 2007 Jul; 41(7):1111-5. PubMed ID: 17595307
[TBL] [Abstract][Full Text] [Related]
4. Comparison of simvastatin tablets from the US and international markets obtained via the Internet.
Veronin MA; Nguyen NT
Ann Pharmacother; 2008 May; 42(5):613-20. PubMed ID: 18413690
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa®.
Gasser UE; Fischer A; Timmermans JP; Arnet I
BMC Pharmacol Toxicol; 2013 Apr; 14():24. PubMed ID: 23617953
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of blend uniformity and content uniformity based on 2003 stratified sampling guidance and 1999 blend uniformity analysis guidance: product A.
Howard-Sparks M; Gawlikowski A;
PDA J Pharm Sci Technol; 2004; 58(4):222-30. PubMed ID: 15368992
[TBL] [Abstract][Full Text] [Related]
7. Dissolution testing of orally disintegrating tablets.
Kraemer J; Gajendran J; Guillot A; Schichtel J; Tuereli A
J Pharm Pharmacol; 2012 Jul; 64(7):911-8. PubMed ID: 22686339
[TBL] [Abstract][Full Text] [Related]
8. Assessment of pharmaceutical quality of furosemide tablets from multinational markets.
Qureshi SA; McGilveray IJ
Drug Dev Ind Pharm; 1998 Nov; 24(11):995-1005. PubMed ID: 9876554
[TBL] [Abstract][Full Text] [Related]
9. In vitro dissolution of generic immediate-release solid oral dosage forms containing BCS class I drugs: comparative assessment of metronidazole, zidovudine, and amoxicillin versus relevant comparator pharmaceutical products in South Africa and India.
Reddy NH; Patnala S; Löbenberg R; Kanfer I
AAPS PharmSciTech; 2014 Oct; 15(5):1076-86. PubMed ID: 24848760
[TBL] [Abstract][Full Text] [Related]
10. Interchangeability between paracetamol tablets marketed in Palestine. Is there a quality reason for a higher price?
Zaid A; Rinno T; Jaradat N; Jodeh S; Khammash S
East Mediterr Health J; 2013 Jun; 19(6):542-6. PubMed ID: 24975183
[TBL] [Abstract][Full Text] [Related]
11. Quality of antiretroviral and opportunistic infection medications dispensed from developing countries and Internet pharmacies.
Wang T; Hoag SW; Eng ML; Polli J; Pandit NS
J Clin Pharm Ther; 2015 Feb; 40(1):68-75. PubMed ID: 25381836
[TBL] [Abstract][Full Text] [Related]
12. Countries Manufacturing Pharmaceuticals for the US Market: A 10-Year Analysis of Public Data.
Hatton RC; Leighton G; Englander L
Ann Pharmacother; 2022 Oct; 56(10):1106-1112. PubMed ID: 35040353
[TBL] [Abstract][Full Text] [Related]
13. Dissolution Failure of Solid Oral Drug Products in Field Alert Reports.
Sun D; Hu M; Browning M; Friedman RL; Jiang W; Zhao L; Wen H
J Pharm Sci; 2017 May; 106(5):1302-1309. PubMed ID: 28104414
[TBL] [Abstract][Full Text] [Related]
14. Affordability and availability of off-patent drugs in the United States-the case for importing from abroad: observational study.
Gupta R; Bollyky TJ; Cohen M; Ross JS; Kesselheim AS
BMJ; 2018 Mar; 360():k831. PubMed ID: 29555641
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the pharmaceutical quality of marketed enteric coated pantoprazole sodium sesquihydrate products.
Mostafa HF; Ibrahim MA; Mahrous GM; Sakr A
Saudi Pharm J; 2011 Apr; 19(2):123-7. PubMed ID: 23960750
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the In-Vitro Dissolution Permeation Systems 1 (IDAS1) as a potential tool to monitor for unexpected changes in generic medicaments in poorly regulated markets.
Rodriguez N; Grosso M; Galvez B; Calderon G; Lau L; Turner VA; Hidalgo IJ
Eur J Pharm Sci; 2021 Jun; 161():105791. PubMed ID: 33691154
[TBL] [Abstract][Full Text] [Related]
17. Dissolution testing for generic drugs: an FDA perspective.
Anand O; Yu LX; Conner DP; Davit BM
AAPS J; 2011 Sep; 13(3):328-35. PubMed ID: 21479700
[TBL] [Abstract][Full Text] [Related]
18. International harmonization of generic drugs: in vitro dissolution tests for Japanese and American generic tablets.
Otsuka M; Tomita H; Otsuka K; Kamae I; Jorgenson JA
Biomed Mater Eng; 2006; 16(2):129-35. PubMed ID: 16477121
[TBL] [Abstract][Full Text] [Related]
19. Pharmacopeial standards and specifications for bulk drugs and solid oral dosage forms. Similarities and differences.
French WN; Matsui F; Cook D; Levi L
J Pharm Sci; 1967 Dec; 56(12):1622-41. PubMed ID: 5588715
[No Abstract] [Full Text] [Related]
20. Packaging and labeling of pharmaceutical products obtained from the internet.
Veronin M
J Med Internet Res; 2011 Feb; 13(1):e22. PubMed ID: 21324833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
